Y-mAbs Therapeutics Inc (NASDAQ:YMAB)

17.29
Delayed Data
As of 3:59pm ET
 -0.45 / -2.54%
Today’s Change
6.50
Today|||52-Week Range
34.60
+6.66%
Year-to-Date

Today’s Trading

Previous close17.74
Today’s open17.29
Day’s range17.14 - 17.87
Volume7,854
Average volume (3 months)416,730
Market cap$798.8M
Data as of 3:59pm ET, 08/17/2022

Growth & Valuation

Earnings growth (last year)+56.97%
Earnings growth (this year)-88.70%
Earnings growth (next 5 years)-88.68%
Revenue growth (last year)+68.18%
P/E ratioNM
Price/Sales20.06
Price/Book4.43

Competitors

 Today’s
change
Today’s
% change
PAHCPhibro Animal Health...-0.37-1.97%
TCDATricida Inc-0.42-3.09%
TBPHTheravance Biopharma...-0.29-2.95%
----
Data as of 3:59pm ET, 08/17/2022

Financials

Next reporting dateNovember 16, 2022
EPS forecast (this quarter)-$0.67
Annual revenue (last year)$34.9M
Annual profit (last year)-$55.3M
Net profit margin-158.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts